Editor's Response to a Letter on "3D Printing Has an Imperative Role in Colitis Management" by Sahoo and Singh

Assay Drug Dev Technol. 2022 Oct;20(7):298-299. doi: 10.1089/adt.2022.29101.bjm. Epub 2022 Oct 11.

Author

Bruce J Melancon^{1

2

3}

Affiliations

¹ Editor-in-Chief.
² Assay and Drug Development Technologies.
³ Department of Pharmacology, Vanderbilt School of Medicine, Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee, USA.

PMID: 36269232
DOI: 10.1089/adt.2022.29101.bjm

No abstract available

Publication types

Letter
Comment

MeSH terms

Colitis* / drug therapy
Humans
Printing, Three-Dimensional*